Patents by Inventor Richard A. Mueller

Richard A. Mueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7141609
    Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Grant
    Filed: April 21, 2005
    Date of Patent: November 28, 2006
    Assignee: G.D. Searle & Co.
    Inventors: Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, John N. Freskos, Deborah E. Bertenshaw, Robert M. Heintz
  • Publication number: 20060264468
    Abstract: N-Substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds of Formula I are effective in treatment of hepatitis infections, including hepatitis B and hepatitis C. In treating hepatitis infections, the compounds of Formula I may be used alone, or in combination with another antiviral agents selected from among nucleosides, nucleotides, immunomodulators, immunostimulants or various combinations of such other agents.
    Type: Application
    Filed: June 22, 2006
    Publication date: November 23, 2006
    Inventors: Richard Mueller, Martin Bryant, Richard Partis
  • Publication number: 20060243672
    Abstract: A method and system of ozone treatment diverts a portion of water from a flow of water in a conduit; injects an ozone-containing gas into the portion to provide an ozonated portion; recombines the ozonated portion with the flow of water in the conduit; and regulates the diverted portion to provide a minimum diverted portion flow rate according to flow in the conduit and proportion of ozone in the injected gas.
    Type: Application
    Filed: September 15, 2005
    Publication date: November 2, 2006
    Inventors: Johannes Leeuwen, Michael Jennings, Richard Mueller, Jack Robinson
  • Publication number: 20060243673
    Abstract: A method and system of ozone treatment diverts a portion of water from a flow of water in a conduit; injects an ozone-containing gas into the portion to provide an ozonated portion; recombines the ozonated portion with the flow of water in the conduit; and controls and regulates the diverted portion to provide a minimum diverted portion flow rate according to flow in the conduit and proportion of ozone in the injected gas.
    Type: Application
    Filed: September 15, 2005
    Publication date: November 2, 2006
    Inventors: Johannes van Leeuwen, Michael Jennings, Richard Mueller, Jack Robinson
  • Patent number: 7115618
    Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: October 3, 2006
    Assignee: G.D. Searle & Co.
    Inventors: Michael J. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, John N. Freskos, Robert M. Heintz, Deborah E. Bertenshaw
  • Publication number: 20060217712
    Abstract: An adjustable spinal implant (10) is provided for use in connecting elongate members (12) as well as vertebral spacers such as corpectomy devices, intervertebral fusion devices, and other prostheses. The implant (10) may have fittings (80) on either end comprising fixed (100) or articulating (200) jaws, endplates, or other engagement structures. The implant (10) comprises a housing (40) with an internal rotor (60); an extending shaft (20); and a locking collar (70). The extending shaft (20) has an external helical groove (23) that meshes with an internal helical groove (63) on rotor (20). Length adjustment occurs by transforming axial movement of the extending shaft (20) into a rotary movement of the rotor (60) via helical engagement. The locking collar (70) comprises protrusion (73) engaging grooves (63) of rotor (60), thus providing a simple, positive locking mechanism without requiring the surgeon to apply excessive force to lock the length.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 28, 2006
    Inventors: Richard Mueller, Andrew Budd, Marc Silski
  • Publication number: 20060200128
    Abstract: A spinal rod bone anchor (00) having a proximal end for engaging a rod (200) and securing the rod with a coming or threaded lock assembly (300) and a distal end for engaging bone. A locking device (300) received within two flanges (110, 120) having an upper wave cap (310) and a lower cap (330) joined by a post with preset timing grooves (335) therein and having camming surfaces therebetween (317, 338).
    Type: Application
    Filed: April 2, 2004
    Publication date: September 7, 2006
    Inventor: Richard Mueller
  • Publication number: 20060195095
    Abstract: An adjustable spinal implant 10 is provided for use in connecting elongate members 12 as well as in vertebral spacers such as corpectomy devices, intervertebral fusion devices, and other prostheses. The implant 10 may have fittings 80 on either end comprising fixed 100 or articulating jaws 200, endplates, or other engagement structures. The implant 10 comprises a housing 40 with an internal rotor 60; an extending shaft 20; and a locking collar 70. The extending shaft 20 has an external helical groove 23 that meshes with an internal helical groove 63 on the rotor 20. Length adjustment occurs by transforming axial movement of the extending shaft 20 into a rotary movement of the rotor 60 via helical engagement. The locking collar 70 comprises protrusion 73 engaging grooves 63 of rotor 60, thus providing a simple, positive locking mechanism without requiring the surgeon to apply excessive force to lock the length.
    Type: Application
    Filed: January 6, 2006
    Publication date: August 31, 2006
    Applicant: Theken Surgical, LLC
    Inventors: Richard Mueller, Andrew Budd, Marc Silski
  • Publication number: 20060166895
    Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: January 13, 2006
    Publication date: July 27, 2006
    Applicant: Monsanto Company (now named Pharmacia Corporation, which is a wholly owned subsidiary of Pfizer, Inc
    Inventors: John Talley, Daniel Getman, Gary DeCrescenzo, Kathryn Reed, Ko-Chung Lin, John Freskos, Michael Clare, Donald Rogier, Robert Heintz, Michael Vazquez, Richard Mueller
  • Publication number: 20060155298
    Abstract: An instrument guide and implant holding device is provided which releasably secures an implant to the instrument guide. The device provides a convenient guide for surgeons to perform various operative techniques on the subject bone without the need for separate devices, and allows all these operative techniques to be performed without removing the instrument guide from the dissected area until all operative techniques have been completed. The releasable mechanism allows the surgeon to easily hold the instrument to an implant using a simple press-fit approach, and easily releases from the implant with a minimal amount of force. An embodiment also allows the surgeon to releasably lock the cannula in a given orientation about the centroidal axis of the implant fastener hole.
    Type: Application
    Filed: February 22, 2006
    Publication date: July 13, 2006
    Applicant: Theken Surgical, LLC
    Inventors: Richard Mueller, Randall Theken, Morton Albert
  • Publication number: 20060094789
    Abstract: ?- and ?-amino acid hydroxyethylamino sulfonyl urea derivative compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: September 27, 2005
    Publication date: May 4, 2006
    Applicant: G.D. Searle & Co.
    Inventors: Michael Vazquez, Richard Mueller, John Talley, Daniel Getman, Gary DeCrescenzo, Eric Sun
  • Publication number: 20060094957
    Abstract: A biopsy assembly suitable for marking of a biopsy site and providing a cut down guide. The assembly includes a pliable filament having an indicator for marking the biopsy site and a stiffener guidable along the filament to provide a cut down guide.
    Type: Application
    Filed: November 1, 2004
    Publication date: May 4, 2006
    Inventors: Richard Mueller, James Kermode
  • Patent number: 7038084
    Abstract: Succinoylamino hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Grant
    Filed: February 24, 2004
    Date of Patent: May 2, 2006
    Assignee: G.D. Searle & Co.
    Inventors: Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel Getman, Gary A. DeCrescenzo, John N. Freskos
  • Patent number: 7037941
    Abstract: Certain Alpha- and Beta-amino acid hydroxyethylamino sulfamic acid derivatives represented by the following formula are useful as retroviral protease inhibitors:
    Type: Grant
    Filed: June 25, 2002
    Date of Patent: May 2, 2006
    Assignee: G. D. Searle & Co.
    Inventors: Michael L Vazquez, Richard A Mueller, John J Talley, Daniel P Getman, Gary A DeCrescenzo, Eric T Sun
  • Patent number: 7030161
    Abstract: ?- and ?-amino acid hydroxyethylamino sulfonyl urea derivative compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Grant
    Filed: October 21, 2003
    Date of Patent: April 18, 2006
    Assignee: G.D. Searle & Co.
    Inventors: Michael L. Vazquez, Richard A. Mueller, John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, Eric T. Sun
  • Patent number: 7026333
    Abstract: HIV protease inhibitors are disclosed which are characterized as having both hydroxyethylamine and N-heterocyclic moieties.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: April 11, 2006
    Assignee: G. D. Searle & Co.
    Inventors: Richard A Mueller, Daniel P. Getman
  • Patent number: 7026485
    Abstract: N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: April 11, 2006
    Assignee: G.D. Searle & Co.
    Inventors: John J. Talley, Daniel P. Getman, Gary A. DeCrescenzo, Kathryn L. Reed, Ko-Chung Lin, John Nicholas Freskos, Michael Clare, Donald Joseph Rogier, Jr., Robert M. Heintz, Michael L. Vazquez, Richard A. Mueller
  • Publication number: 20060040974
    Abstract: HIV protease inhibitors are disclosed which are characterized as having both hydroxyethylamine and N-heterocyclic moieties.
    Type: Application
    Filed: August 9, 2005
    Publication date: February 23, 2006
    Applicant: G.D. Searle & Co.
    Inventors: Richard Mueller, Daniel Getman
  • Publication number: 20060027507
    Abstract: A method and system treat ballast-water with ozone without release of detrimental off-gas into the atmosphere.
    Type: Application
    Filed: October 11, 2005
    Publication date: February 9, 2006
    Inventors: Johannes van Leeuwen, Michael Jennings, Richard Mueller, Jack Robinson
  • Publication number: 20060021951
    Abstract: A method and system of ozone treatment diverts a portion of water from a flow of water in a conduit, injects ozone into the portion to provide an ozonated portion, and recombines the ozonated portion with the flow of water in the conduit. Another method and system identifies a species-destructive reaction product of ozone with a water constituent, determines a life of the reaction product, and contacts ozone with a water containing the species for a period determined according to the determined life of the reaction product.
    Type: Application
    Filed: September 21, 2005
    Publication date: February 2, 2006
    Inventors: Johannes Leeuwen, Michael Jennings, Richard Mueller, Jack Robinson